BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38870440)

  • 1. The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
    Young CB; Cholerton B; Smith AM; Shahid-Besanti M; Abdelnour C; Mormino EC; Hu SC; Chung KA; Peterson A; Rosenthal L; Pantelyat A; Dawson TM; Quinn J; Zabetian CP; Montine TJ; Poston KL
    Neurology; 2024 Jul; 103(2):e209609. PubMed ID: 38870440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study.
    Mills KA; Schneider RB; Saint-Hilaire M; Ross GW; Hauser RA; Lang AE; Halverson MJ; Oakes D; Eberly S; Litvan I; Blindauer K; Aquino C; Simuni T; Marras C
    Parkinsonism Relat Disord; 2020 Nov; 80():127-132. PubMed ID: 32987359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responsiveness to Change of the Montreal Cognitive Assessment, Mini-Mental State Examination, and SCOPA-Cog in Non-Demented Patients with Parkinson's Disease.
    Faust-Socher A; Duff-Canning S; Grabovsky A; Armstrong MJ; Rothberg B; Eslinger PJ; Meaney CA; Schneider RB; Tang-Wai DF; Fox SH; Zadikoff C; Kennedy N; Chou KL; Persad C; Litvan I; Mast BT; Gerstenecker AT; Weintraub S; Reginold W; Marras C
    Dement Geriatr Cogn Disord; 2019; 47(4-6):187-197. PubMed ID: 31315127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-Analysis of Cognition in Parkinson's Disease Mild Cognitive Impairment and Dementia Progression.
    Wallace ER; Segerstrom SC; van Horne CG; Schmitt FA; Koehl LM
    Neuropsychol Rev; 2022 Mar; 32(1):149-160. PubMed ID: 33860906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective cognitive decline and progression to dementia in Parkinson's disease: a long-term follow-up study.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Neurol; 2019 Mar; 266(3):745-754. PubMed ID: 30635723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor structure of the Montreal Cognitive Assessment in Parkinson disease.
    Smith CR; Cavanagh J; Sheridan M; Grosset KA; Cullen B; Grosset DG
    Int J Geriatr Psychiatry; 2020 Feb; 35(2):188-194. PubMed ID: 31736141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild Cognitive Impairment in Parkinson's Disease: Clustering and Switching Analyses in Verbal Fluency Test.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Int Neuropsychol Soc; 2017 Jul; 23(6):511-520. PubMed ID: 28494819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theory of mind in mild cognitive impairment and Parkinson's disease: The role of memory impairment.
    Maggi G; Giacobbe C; Vitale C; Amboni M; Obeso I; Santangelo G
    Cogn Affect Behav Neurosci; 2024 Feb; 24(1):156-170. PubMed ID: 38049608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical characteristics and cognitive features of mild cognitive impairment in Parkinson's disease and the analysis of relevant factors.
    Nie K; Gao Y; Mei M; Guo M; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
    J Clin Neurosci; 2019 May; 63():142-148. PubMed ID: 30732989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Domain specific cognitive impairment in Parkinson's patients with mild cognitive impairment.
    Chaudhary S; Kumaran SS; Kaloiya GS; Goyal V; Sagar R; Kalaivani M; Jaganathan NR; Mehta N; Srivastava A
    J Clin Neurosci; 2020 May; 75():99-105. PubMed ID: 32192853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated Indices of Clustering and Switching of Semantic Verbal Fluency in Parkinson's Disease.
    Farzanfar D; Statucka M; Cohn M
    J Int Neuropsychol Soc; 2018 Nov; 24(10):1047-1056. PubMed ID: 30282568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment, psychiatric symptoms, and executive functioning in patients with Parkinson's disease.
    Petkus AJ; Filoteo JV; Schiehser DM; Gomez ME; Hui JS; Jarrahi B; McEwen S; Jakowec MW; Petzinger GM
    Int J Geriatr Psychiatry; 2020 Apr; 35(4):396-404. PubMed ID: 31894601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia.
    Gomperts SN; Locascio JJ; Rentz D; Santarlasci A; Marquie M; Johnson KA; Growdon JH
    Neurology; 2013 Jan; 80(1):85-91. PubMed ID: 23243071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.